Patents by Inventor Mary Jane Helenek

Mary Jane Helenek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230008240
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Application
    Filed: June 16, 2022
    Publication date: January 12, 2023
    Applicant: American Regent, Inc.
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Patent number: 11478502
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: October 25, 2022
    Assignee: American Regent, Inc.
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Patent number: 11433091
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: September 6, 2022
    Assignee: American Regent, Inc.
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Patent number: 11406656
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: August 9, 2022
    Assignee: American Regent, Inc.
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Patent number: 11364260
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: June 21, 2022
    Assignee: American Regent, Inc.
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Patent number: 11344568
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: May 31, 2022
    Assignee: American Regent, Inc.
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Publication number: 20200215097
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Application
    Filed: March 20, 2020
    Publication date: July 9, 2020
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Publication number: 20200215096
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Application
    Filed: March 20, 2020
    Publication date: July 9, 2020
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Patent number: 10603336
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: March 31, 2020
    Assignee: American Regent, Inc.
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Patent number: 10478450
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: November 19, 2019
    Assignee: Luitpold Pharmaceuticals, Inc.
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Publication number: 20190328771
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Application
    Filed: June 11, 2019
    Publication date: October 31, 2019
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Patent number: 10434118
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: October 8, 2019
    Assignee: Luitpold Pharmaceuticals, Inc.
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Patent number: 10391117
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: August 27, 2019
    Assignee: Luitpold Pharmaceuticals, Inc.
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Patent number: 10314856
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: June 11, 2019
    Assignee: Luitpold Pharmaceuticals, Inc.
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Publication number: 20190083524
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Application
    Filed: November 15, 2018
    Publication date: March 21, 2019
    Inventors: Mary Jane HELENEK, Marc L. Tokars, Richard P. Lawrence
  • Publication number: 20180235997
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Application
    Filed: April 20, 2018
    Publication date: August 23, 2018
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Publication number: 20150297630
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Application
    Filed: April 10, 2015
    Publication date: October 22, 2015
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Patent number: 8895612
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: November 25, 2014
    Assignee: Luitpold Pharmaceuticals, Inc.
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Publication number: 20140099381
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Application
    Filed: December 9, 2013
    Publication date: April 10, 2014
    Applicant: Luitpold Pharmaceuticals, Inc.
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
  • Publication number: 20130230565
    Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
    Type: Application
    Filed: March 19, 2013
    Publication date: September 5, 2013
    Applicant: Luitpold Pharmaceuticals, Inc.
    Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence